* Sotera Health Co SHC.OQ SHC.O is expected to show a
rise in
quarterly revenue when it reports results on February 28.
* The Broadview Heights Ohio-based company is expected to
report
a 2.6% increase in revenue to $247.548 million from $241.25
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Sotera Health Co is
for
earnings of 22 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sotera
Health Co
is $8, below its last closing price of $17.91.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.22 0.22 0.23 Beat 2.8
Jun. 30 2022 0.24 0.24 0.27 Beat 11.3
Mar. 31 2022 0.19 0.19 0.22 Beat 13.6
Dec. 31 2021 0.22 0.22 0.23 Beat 3.8
Sep. 0.20 0.20 0.21 Beat 2.7
30 2021
Jun. 30 2021 0.21 0.21 0.26 Beat 24.7
Mar. 31 2021 0.16 0.16 0.18 Beat 11.6
Dec. 31 2020 0.07 0.07 0.09 Beat 29.7
This summary was machine generated February 24 at 19:34 GMT.
All figures in US dollars unless otherwise stated